hg_239325.1

Basic information about the TSS

---

TSS ID: hg_239325.1 Species: human Chr: chr22		Start: 24556027 End: 24556030 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000439775.1 Distance: 2 GeneID: HGNC/MGI_ID: UniProt_ID: H3BT13

Gene_name: HSPD1 Gene_symbol: HSPE1 Gene_synonyms: CPN10 EPF GroES HSP10 Gene_source: HGNC:5269

TATA-Box annotation

---

Distance to TSS:	99
Nearest PromoterID:	NM_199440
Entrez ID:	3329
Nearest Unigene:	Hs.595053
Nearest Refseq:	NM_002156
Nearest Ensembl:	ENSG00000144381
Gene Name:	HSPD1
Gene Alias:	CPN60|GROEL|HLD4|HSP-60|HSP60|HSP65|HuCHA60|SPG13
Gene Description:	heat shock protein family D (Hsp60) member 1
Gene Type:	protein-coding
CpG%:	0.11
GC%:	0.61194
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	-4(GCCTAGAAAAGC,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p2@HSPE1 p3@HSPE1
Sample		p2@HSPE1	p3@HSPE1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	50.06	13.44
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	49.97	15.38
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	55.17	15.05
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	39.09	10.60
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	40.94	12.60
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	41.86	11.43
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	82.58	16.78
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	69.27	16.96
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	60.48	12.40
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.91	6.38
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.49	4.04
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	8.94	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	32.08	5.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	36.99	6.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	42.37	8.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	29.17	6.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	30.58	5.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	29.95	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	22.93	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	49.04	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	40.36	8.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	49.72	7.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	32.83	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	39.80	8.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	45.15	6.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	38.93	7.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	40.11	5.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	45.26	7.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	41.83	5.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	43.97	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	39.15	7.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	44.16	7.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	42.63	5.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	55.75	9.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	47.12	6.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	32.96	7.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	48.44	8.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	40.50	4.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	55.91	10.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	48.49	5.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	40.23	5.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	47.29	6.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	49.14	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	47.03	6.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	53.20	8.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	51.88	7.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	43.42	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	53.65	11.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	44.52	3.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	52.17	5.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	44.68	4.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	49.59	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	293.84	83.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	31.58	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	29.49	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	206.38	21.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	84.50	6.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	47.00	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	36.93	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	80.47	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.84	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	31.40	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	85.19	8.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	46.55	5.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	23.07	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	28.40	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	48.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	244.82	63.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	41.44	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	34.22	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	29.09	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	58.62	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	53.21	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	34.55	1.22
Adipocyte - breast, donor1	11376-118A8	31.04	3.80
Adipocyte - breast, donor2	11327-117E4	38.82	7.22
Adipocyte - omental, donor1	11473-119C6	31.04	8.52
Adipocyte - omental, donor2	11474-119C7	50.08	6.73
Adipocyte - omental, donor3	11475-119C8	46.22	8.04
Adipocyte - perirenal, donor1	11476-119C9	55.51	12.12
Adipocyte - subcutaneous, donor1	11259-116F8	21.99	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	32.07	7.23
Adipocyte - subcutaneous, donor3	11408-118E4	22.42	4.69
Adipocyte differentiation, day04, donor1	13019-139D4	36.57	12.32
Adipocyte differentiation, day04, donor2	13022-139D7	27.54	3.35
Adipocyte differentiation, day04, donor3	13025-139E1	44.05	5.85
Adipocyte differentiation, day04, donor4	13028-139E4	30.57	7.64
Adipocyte differentiation, day08, donor1	13020-139D5	51.08	15.60
Adipocyte differentiation, day08, donor2	13023-139D8	31.31	6.78
Adipocyte differentiation, day08, donor3	13026-139E2	25.59	8.00
Adipocyte differentiation, day08, donor4	13029-139E5	26.71	7.79
Adipocyte differentiation, day12, donor1	13021-139D6	48.24	8.32
Adipocyte differentiation, day12, donor2	13024-139D9	33.66	7.53
Adipocyte differentiation, day12, donor3	13027-139E3	26.18	7.85
Adipocyte differentiation, day12, donor4	13030-139E6	26.18	6.39
Alveolar Epithelial Cells, donor1	11510-119G7	59.23	9.72
Alveolar Epithelial Cells, donor2	11590-120G6	14.70	2.51
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	19.61	2.16
Amniotic Epithelial Cells, donor2	11613-122A2	20.08	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	24.04	1.44
Anulus Pulposus Cell, donor1	11248-116E6	26.55	1.60
Anulus Pulposus Cell, donor2	11463-119B5	35.02	2.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	75.03	3.15
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	64.25	5.64
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	42.80	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	53.81	6.88
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	75.88	8.85
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	54.79	3.96
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	56.21	3.90
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	62.14	4.85
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	45.73	4.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	62.90	5.65
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	52.25	5.81
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	40.12	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	38.38	5.44
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	53.23	16.38
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	43.13	5.88
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	57.86	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	48.37	4.72
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	56.40	4.81
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	55.60	6.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	54.24	4.64
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	51.63	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	48.54	4.97
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	37.75	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	65.53	5.83
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	54.26	7.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	31.50	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	66.69	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	49.60	3.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	44.65	2.84
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	62.87	7.04
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	47.27	4.50
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	38.53	3.57
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	53.82	3.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	61.12	6.32
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	71.28	9.50
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	74.76	5.59
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	74.11	7.90
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	50.83	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	59.55	3.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	54.83	4.87
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	46.11	2.32
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	63.30	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	50.01	5.76
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	59.15	14.79
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	45.88	6.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	54.15	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	62.69	6.56
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	61.38	4.14
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	61.21	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	55.17	5.08
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	49.75	7.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	42.84	4.90
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	63.58	7.65
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	47.90	4.21
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	39.67	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	52.07	3.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	45.81	6.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	51.25	2.18
Astrocyte - cerebellum, donor1	11500-119F6	61.29	6.88
Astrocyte - cerebellum, donor2	11580-120F5	49.81	2.74
Astrocyte - cerebellum, donor3	11661-122F5	17.62	1.68
Astrocyte - cerebral cortex, donor1	11235-116D2	67.28	7.32
Astrocyte - cerebral cortex, donor2	11316-117D2	115.02	9.71
Astrocyte - cerebral cortex, donor3	11392-118C6	96.06	4.47
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	141.75	24.20
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	171.89	30.44
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	166.71	24.81
Basophils, donor1	12241-129G9	9.15	5.49
Basophils, donor2	12242-129H1	20.93	9.38
Basophils, donor3	12243-129H2	7.06	5.44
Bronchial Epithelial Cell, donor1	11511-119G8	13.80	4.10
Bronchial Epithelial Cell, donor2	11591-120G7	6.86	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	78.91	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	68.41	10.04
Bronchial Epithelial Cell, donor5	11457-119A8	23.91	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	17.96	2.30
Bronchial Epithelial Cell, donor7	11769-123I5	49.84	5.04
Burkitt's lymphoma cell line:DAUDI	10422-106C8	118.62	17.11
Burkitt's lymphoma cell line:RAJI	10476-106I8	195.17	27.48
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	74.19	16.31
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	7.33	1.69
CD14+ Monocytes, donor2	11305-117B9	10.21	2.23
CD14+ Monocytes, donor3	11381-118B4	9.88	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	34.53	3.11
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	29.19	6.82
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	27.61	3.62
CD14+ monocytes - mock treated, donor1	11863-125A9	5.35	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	5.43	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	9.71	4.03
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.03	3.35
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	7.73	2.76
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	11.16	7.93
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.05	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	9.79	2.85
CD14+ monocytes - treated with BCG, donor3	11880-125C8	14.36	8.05
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.73	3.98
CD14+ monocytes - treated with Candida, donor2	11878-125C6	19.01	7.92
CD14+ monocytes - treated with Candida, donor3	11888-125D7	25.52	5.55
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.31	1.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.58	2.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	14.16	6.87
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.26	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.27	3.39
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.86	4.36
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.19	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.99	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	12.20	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.31	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.40	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	7.02	3.51
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.32	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	11.15	2.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.03	9.48
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.60	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.26	2.09
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.82	4.87
CD14+CD16+ Monocytes, donor1	11789-124B7	27.68	2.40
CD14+CD16+ Monocytes, donor2	11801-124D1	27.72	2.77
CD14+CD16+ Monocytes, donor3	11912-125G4	36.39	4.98
CD14+CD16- Monocytes, donor1	11788-124B6	21.96	2.49
CD14+CD16- Monocytes, donor2	11799-124C8	20.26	2.10
CD14+CD16- Monocytes, donor3	11910-125G2	20.29	2.23
CD14-CD16+ Monocytes, donor1	11790-124B8	35.98	1.79
CD14-CD16+ Monocytes, donor2	11800-124C9	25.91	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	29.27	2.32
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	44.71	8.13
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	46.10	11.53
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	51.78	6.21
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	51.17	9.06
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	54.68	6.43
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	46.33	7.02
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.08	7.06
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	43.50	11.86
CD19+ B Cells, donor1	11544-120B5	14.79	13.97
CD19+ B Cells, donor2	11624-122B4	18.86	17.41
CD19+ B Cells, donor3	11705-123B4	12.12	15.65
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	113.54	11.72
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	113.46	9.19
CD34+ Progenitors, donor1	11545-120B6	17.07	3.01
CD34+ Progenitors, donor2	11625-122B5	24.16	12.92
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	85.67	19.16
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	106.88	18.26
CD4+ T Cells, donor1	11225-116C1	17.14	5.36
CD4+ T Cells, donor2	11306-117C1	29.39	7.35
CD4+ T Cells, donor3	11382-118B5	22.87	9.76
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	53.34	5.36
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	53.23	6.96
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	41.39	4.02
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	43.14	11.85
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	47.06	10.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	19.78
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	29.77	7.08
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	49.31	3.56
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	45.46	5.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	27.79	8.07
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	35.99	5.24
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	26.84	4.40
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.48	6.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	46.54	5.82
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	37.09	4.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	42.15	5.17
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	47.70	5.36
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	43.04	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	40.61	9.27
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	34.01	7.58
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	27.95	4.83
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	41.97	12.64
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	39.86	6.50
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	42.71	10.90
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	61.36	7.42
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	63.70	9.23
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	83.75	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	68.68	8.31
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	75.09	10.31
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	60.06	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	55.87	8.24
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	54.01	5.54
CD8+ T Cells, donor1	11226-116C2	18.01	14.73
CD8+ T Cells, donor2	11307-117C2	18.02	16.89
CD8+ T Cells, donor3	11383-118B6	23.99	10.10
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	70.19	10.55
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	64.22	6.71
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	70.86	10.94
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	74.45	14.11
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	51.60	6.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	40.47	10.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	91.04	14.56
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	91.07	13.16
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	91.70	13.37
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	73.05	9.96
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	72.05	14.82
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	63.41	12.26
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.51	5.69
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	27.78	6.38
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.14	5.97
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	48.62	8.28
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	51.79	6.91
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	43.37	6.13
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	90.00	13.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	79.04	16.30
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	77.90	13.46
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	71.90	9.94
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	59.12	9.46
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	51.44	11.35
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	19.27	9.64
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	24.48	14.69
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	24.04	17.03
Cardiac Myocyte, donor1	11525-119I4	62.14	1.83
Cardiac Myocyte, donor2	11605-120I3	41.50	5.43
Cardiac Myocyte, donor3	11686-122I3	30.31	8.21
Chondrocyte - de diff, donor1	11261-116G1	60.32	13.52
Chondrocyte - de diff, donor2	11338-117F6	14.22	1.78
Chondrocyte - de diff, donor3	11410-118E6	23.67	4.55
Chondrocyte - re diff, donor2	11339-117F7	24.17	2.69
Chondrocyte - re diff, donor3	11411-118E7	17.79	2.83
Ciliary Epithelial Cells, donor1	11242-116D9	81.48	5.51
Ciliary Epithelial Cells, donor2	11323-117D9	77.38	5.13
Ciliary Epithelial Cells, donor3	11399-118D4	64.60	4.60
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	26.68	6.97
Corneal Epithelial Cells, donor1	11526-119I5	13.83	1.76
Corneal Epithelial Cells, donor2	11606-120I4	25.03	1.14
Corneal Epithelial Cells, donor3	11687-122I4	34.25	2.81
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	30.05	10.07
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	42.58	11.35
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	32.40	5.51
Dendritic Cells - plasmacytoid, donor1	11228-116C4	19.13	7.86
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.85	7.83
Dendritic Cells - plasmacytoid, donor3	11385-118B8	31.94	10.16
Endothelial Cells - Aortic, donor0	11207-116A1	22.01	1.83
Endothelial Cells - Aortic, donor1	11263-116G3	24.64	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	22.34	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	18.09	2.36
Endothelial Cells - Artery, donor1	11264-116G4	34.03	3.20
Endothelial Cells - Artery, donor2	11341-117F9	43.53	3.76
Endothelial Cells - Artery, donor3	11413-118E9	29.98	2.98
Endothelial Cells - Lymphatic, donor1	11236-116D3	40.34	6.65
Endothelial Cells - Lymphatic, donor2	11317-117D3	32.25	6.09
Endothelial Cells - Lymphatic, donor3	11393-118C7	22.55	3.38
Endothelial Cells - Microvascular, donor1	11265-116G5	24.96	4.75
Endothelial Cells - Microvascular, donor2	11342-117G1	18.74	3.12
Endothelial Cells - Microvascular, donor3	11414-118F1	7.94	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	97.63	17.21
Endothelial Cells - Thoracic, donor2	11343-117G2	29.88	3.14
Endothelial Cells - Umbilical vein, donor1	11243-116E1	96.04	8.45
Endothelial Cells - Umbilical vein, donor2	11324-117E1	68.22	6.08
Endothelial Cells - Umbilical vein, donor3	11400-118D5	82.80	5.50
Endothelial Cells - Vein, donor1	11267-116G7	26.16	6.83
Endothelial Cells - Vein, donor2	11344-117G3	23.05	1.40
Endothelial Cells - Vein, donor3	11416-118F3	36.27	3.30
Eosinophils, donor1	12244-129H3	0.00	0.00
Eosinophils, donor2	12245-129H4	8.25	1.65
Eosinophils, donor3	12246-129H5	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	19.79	4.15
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	30.38	4.93
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	23.21	3.28
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	46.91	3.58
Fibroblast - Aortic Adventitial, donor1	11245-116E3	51.42	8.13
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	18.70	6.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	31.32	2.43
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	22.92	4.22
Fibroblast - Aortic Adventitial, donor3	11401-118D6	63.12	3.65
Fibroblast - Cardiac, donor1	11268-116G8	23.13	6.35
Fibroblast - Cardiac, donor2	11345-117G4	18.19	0.00
Fibroblast - Cardiac, donor3	11417-118F4	20.82	3.00
Fibroblast - Cardiac, donor4	11452-119A3	27.58	3.94
Fibroblast - Cardiac, donor5	11456-119A7	53.68	4.44
Fibroblast - Cardiac, donor6	11460-119B2	93.84	10.31
Fibroblast - Choroid Plexus, donor1	11492-119E7	22.78	3.62
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.28	3.88
Fibroblast - Choroid Plexus, donor3	11653-122E6	93.75	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	16.38	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	19.50	2.20
Fibroblast - Dermal, donor1	11269-116G9	71.61	9.86
Fibroblast - Dermal, donor2	11346-117G5	39.15	2.83
Fibroblast - Dermal, donor3	11418-118F5	58.87	5.92
Fibroblast - Dermal, donor4	11450-119A1	140.40	6.67
Fibroblast - Dermal, donor5	11454-119A5	186.49	12.04
Fibroblast - Dermal, donor6	11458-119A9	228.53	14.62
Fibroblast - Gingival, donor1	11237-116D4	49.56	2.71
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	34.32	2.10
Fibroblast - Gingival, donor2	11318-117D4	122.69	7.25
Fibroblast - Gingival, donor3	11394-118C8	25.24	1.26
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.33	3.52
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	58.77	6.55
Fibroblast - Gingival, donor6 (control)	11922-125H5	55.98	2.30
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.17	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	54.11	3.51
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	58.77	3.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	85.01	5.16
Fibroblast - Gingival, donor9 (control)	11927-125I1	20.84	1.61
Fibroblast - Lung, donor1	11270-116H1	16.31	1.36
Fibroblast - Lung, donor2	11347-117G6	43.27	14.92
Fibroblast - Lung, donor3	11419-118F6	64.79	3.59
Fibroblast - Lymphatic, donor1	11506-119G3	29.99	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	22.38	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	7.56	0.28
Fibroblast - Mammary, donor1	11540-120B1	35.73	3.25
Fibroblast - Mammary, donor2	11620-122A9	31.95	0.00
Fibroblast - Mammary, donor3	11701-123A9	53.61	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	117.94	7.56
Fibroblast - Periodontal Ligament, donor2	11319-117D5	131.05	6.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	48.04	4.59
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.73	3.43
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	39.96	3.24
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	23.43	1.86
Fibroblast - Pulmonary Artery, donor1	11250-116E8	94.62	14.15
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	27.23	4.27
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	37.42	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	47.05	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	28.18	4.37
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.36	3.20
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	34.29	5.32
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	24.37	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	49.77	6.37
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	16.20	3.80
Fibroblast - skin normal, donor1	11553-120C5	22.97	3.77
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	29.68	4.41
Fibroblast - skin normal, donor2	11561-120D4	52.54	6.43
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	27.50	4.23
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	25.77	2.82
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	42.57	7.01
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	16.75	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	61.04	8.10
Fibroblast - skin walker warburg, donor1	11554-120C6	52.12	7.42
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	51.44	5.33
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	997.19	132.96
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	22.66	7.84
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	35.89	5.37
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	42.16	8.85
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	42.93	7.92
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	165.36	6.12
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	225.24	9.57
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	739.40	69.32
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	122.99	11.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	108.46	16.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	395.67	33.09
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	143.80	12.95
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	85.45	12.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	673.95	58.82
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	199.97	15.55
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	136.81	9.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	159.56	13.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	105.68	8.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	132.47	7.48
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	136.42	13.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	77.12	9.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	98.78	7.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	80.44	8.52
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	77.42	10.93
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	99.51	8.90
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	89.59	9.16
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	61.30	10.28
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	83.46	11.87
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	77.41	14.36
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	49.53	10.61
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	44.91	11.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	65.62	12.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	65.48	15.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	56.76	21.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	58.80	6.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	53.15	7.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	44.86	11.51
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	37.69	8.16
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	70.84	11.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	50.25	12.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	57.41	7.70
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	50.03	9.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	36.06	11.55
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	53.52	10.64
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	56.45	10.45
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.54	10.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	40.40	10.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	39.72	10.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	50.00	12.57
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	50.95	15.76
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	59.33	12.82
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	32.80	13.28
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	45.17	10.69
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	34.65	7.46
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	4.96
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	38.91	4.62
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.94	5.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	17.28	6.35
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	328.05	36.03
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	224.49	13.56
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	233.02	10.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	243.15	29.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	237.63	31.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	214.00	19.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	180.66	19.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	218.55	27.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	218.21	19.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	132.15	17.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	179.01	23.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	200.14	21.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	106.63	16.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	147.09	21.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	165.71	17.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	107.37	14.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	120.23	14.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	146.05	13.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	183.76	27.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	147.76	13.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	82.58	5.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	88.10	28.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	134.20	17.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	111.38	19.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	110.64	26.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	86.11	12.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	82.14	15.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	97.65	23.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	88.23	7.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	94.14	17.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	82.00	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	103.34	10.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	88.11	6.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	74.27	14.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	113.67	15.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	80.91	14.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	121.59	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	88.68	11.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	84.27	6.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	61.88	10.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	67.45	17.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	79.10	15.04
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	18.30	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	21.36	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	24.74	2.85
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.48	4.18
Hep-2 cells mock treated, biol_rep1	11898-125E8	131.94	25.76
Hep-2 cells mock treated, biol_rep2	11899-125E9	110.56	23.80
Hep-2 cells mock treated, biol_rep3	11900-125F1	116.03	22.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	127.67	26.34
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	102.94	23.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	102.47	18.73
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	115.32	22.91
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	101.73	20.24
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	103.48	20.50
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	45.89	3.92
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	24.67	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	111.04	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	21.16	3.53
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	97.56	12.59
Hepatocyte, donor1	11523-119I2	85.95	33.90
Hepatocyte, donor2	11603-120I1	65.72	18.31
Hepatocyte, donor3	11684-122I1	70.56	33.74
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	116.83	17.62
Intestinal epithelial cells (polarized), donor1	11246-116E4	79.18	21.50
Iris Pigment Epithelial Cells, donor1	11530-119I9	70.11	12.49
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	37.38	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	27.61	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	26.68	8.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	30.44	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	25.50	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	49.13	7.56
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	51.04	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	38.64	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	36.67	5.70
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	14.69	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	49.83	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	27.70	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	36.82	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	38.09	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	39.82	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	36.84	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	31.88	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	34.63	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	49.27	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	54.02	5.86
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	31.61	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	31.99	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	25.29	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	24.54	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	27.71	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	39.89	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	28.53	4.60
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	0.00
Keratinocyte - epidermal, donor1	11272-116H3	28.64	2.86
Keratinocyte - epidermal, donor2	11349-117G8	9.37	0.59
Keratinocyte - epidermal, donor3	11421-118F8	66.54	5.68
Keratinocyte - oral, donor1	11251-116E9	69.93	3.29
Keratocytes, donor1	11527-119I6	17.54	2.75
Keratocytes, donor2	11607-120I5	49.22	1.17
Keratocytes, donor3	11688-122I5	33.00	2.77
Krukenberg tumor cell line:HSKTC	10687-109F3	28.57	17.58
Lens Epithelial Cells, donor1	11529-119I8	86.30	2.16
Lens Epithelial Cells, donor2	11609-120I7	44.98	6.46
Lens Epithelial Cells, donor3	11690-122I7	26.14	5.75
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	38.18	4.51
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	35.72	2.51
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	55.57	9.92
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	47.86	8.07
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	31.83	3.78
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	37.74	6.90
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	41.04	3.69
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	17.70	1.52
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	35.19	4.93
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	39.16	3.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	35.29	5.23
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.11	3.15
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	41.81	6.97
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	34.82	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	37.36	2.88
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	41.27	5.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	22.45	4.68
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	31.11	2.74
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	39.82	3.62
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	23.43	2.64
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	20.91	3.98
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	38.80	5.82
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	37.43	3.77
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	39.96	4.54
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	39.40	5.70
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	40.62	3.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	39.10	4.36
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	40.58	5.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	28.03	4.33
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	26.51	3.39
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	34.41	3.39
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	25.14	3.31
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	28.25	3.84
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	46.65	5.55
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	36.07	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	26.26	2.06
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	37.95	4.50
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	40.17	4.56
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	47.87	8.82
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	42.31	2.49
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	24.24	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	18.21	2.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	51.93	8.95
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	25.48	3.27
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	23.31	3.30
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	37.87	6.93
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.27	1.54
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	29.24	5.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	38.36	4.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	32.66	3.71
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	42.74	3.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	38.68	4.22
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.02	6.54
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	38.65	3.61
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	46.39	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.69	3.85
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	63.40	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	53.57	6.30
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	33.47	4.88
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	47.76	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	41.99	2.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	39.98	8.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	45.34	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	48.83	3.47
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	64.62	6.99
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	42.34	5.52
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	42.40	4.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	61.02	7.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	65.02	5.32
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	59.76	7.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	61.83	7.84
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	60.08	3.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	54.22	6.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	55.85	6.01
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	57.90	2.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	52.96	5.76
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	47.20	4.22
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	48.69	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	31.18	4.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	36.60	6.78
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	46.68	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	52.28	5.23
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	37.16	4.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	50.40	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	43.67	7.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	52.98	4.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	36.80	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	31.28	5.69
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	37.47	4.81
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	42.94	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	43.77	4.71
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	46.67	4.82
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	44.19	4.65
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	35.96	5.29
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	38.41	4.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	32.71	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	33.73	6.90
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	43.41	6.41
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	37.64	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	33.69	4.53
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	41.46	5.41
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	41.86	6.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	43.79	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.99	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	37.36	6.23
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	43.76	3.94
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	47.52	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	38.42	4.86
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	47.44	5.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	44.56	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	40.37	5.29
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	37.37	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	49.82	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	47.04	4.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	44.46	4.18
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	51.13	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	38.09	7.26
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	46.90	5.70
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	50.11	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	55.17	5.75
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	43.71	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	40.32	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	47.10	3.97
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	43.27	4.58
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	43.07	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	44.68	4.59
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	46.46	6.04
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	34.79	4.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	41.17	6.95
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	49.70	4.04
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	44.05	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	41.79	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	35.90	5.13
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	42.95	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	63.47	9.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	37.42	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	35.09	5.46
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	59.68	7.29
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	58.20	2.08
Macrophage - monocyte derived, donor1	11232-116C8	33.05	8.20
Macrophage - monocyte derived, donor2	11313-117C8	36.52	8.81
Macrophage - monocyte derived, donor3	11389-118C3	30.54	3.93
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	37.70	4.25
Mallassez-derived cells, donor2	11929-125I3	34.07	6.81
Mallassez-derived cells, donor3	11930-125I4	72.27	14.45
Mammary Epithelial Cell, donor1	11273-116H4	34.78	7.97
Mammary Epithelial Cell, donor2	11350-117G9	51.54	8.69
Mammary Epithelial Cell, donor3	11422-118F9	22.45	0.25
Mast cell - stimulated, donor1	11487-119E2	43.39	10.85
Mast cell, donor1	11563-120D6	35.04	7.25
Mast cell, donor2	11565-120D8	55.57	41.01
Mast cell, donor3	11566-120D9	54.71	18.24
Mast cell, donor4	11567-120E1	60.10	55.31
Mast cell, expanded and stimulated, donor5	11940-126A5	72.30	8.76
Mast cell, expanded and stimulated, donor8	11942-126A7	69.46	7.00
Mast cell, expanded, donor5	11939-126A4	50.02	5.16
Mast cell, expanded, donor8	11941-126A6	30.96	2.34
Melanocyte - dark, donor1	11502-119F8	44.08	6.77
Melanocyte - dark, donor2	11582-120F7	41.53	2.77
Melanocyte - dark, donor3	11663-122F7	43.25	26.22
Melanocyte - light, donor1	11274-116H5	6.11	3.53
Melanocyte - light, donor2	11351-117H1	5.46	0.68
Melanocyte - light, donor3	11423-118G1	7.81	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	82.26	16.24
Melanocyte, donor2 (MC+2)	12739-135I3	43.03	11.83
Melanocyte, donor3 (MC+3)	12837-137B2	29.46	7.77
Meningeal Cells, donor1	11493-119E8	71.09	9.06
Meningeal Cells, donor2	11573-120E7	82.31	5.72
Meningeal Cells, donor3	11654-122E7	102.04	11.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	101.23	6.27
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	35.83	6.54
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	24.86	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	93.29	10.05
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	21.18	3.39
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	46.75	5.53
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	56.04	5.27
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	79.63	5.11
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	56.27	1.84
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	41.69	5.12
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.09	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	30.92	4.74
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.04	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	58.28	3.84
Mesenchymal stem cells - adipose, donor0	11217-116B2	132.56	16.30
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.96	3.75
Mesenchymal stem cells - umbilical, donor0	11214-116A8	136.43	10.89
Mesothelial Cells, donor1	11247-116E5	57.01	8.22
Mesothelial Cells, donor2	12156-128G5	40.04	6.51
Mesothelial Cells, donor3	11402-118D7	51.38	4.77
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	38.67	7.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	21.20	2.65
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	34.09	9.30
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	24.89	4.36
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	31.53	6.01
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	16.76	2.33
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	29.26	4.06
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	24.95	3.17
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	29.20	7.08
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	41.03	3.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.47	7.43
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.60	4.17
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	28.35	6.77
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	16.40	2.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.08	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	24.18	5.30
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	17.88	4.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	15.29	2.24
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.03	4.72
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.34	2.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.77	3.29
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.60	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.94	3.26
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	16.17	1.76
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.94	4.32
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	19.61	2.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	4.11
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	15.52	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.39	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.82	5.95
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	2.78
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	24.62	5.13
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.75	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.59	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	28.62	7.29
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	20.37	3.33
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.99	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	16.29	4.52
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	30.89	4.17
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	18.47	3.69
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	30.16	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.35	3.04
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	24.88	4.41
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.31	5.15
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	2.54	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.41	4.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	23.95	4.49
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.27	2.54
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	29.62	4.14
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	39.58	5.97
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.58	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	25.57	4.26
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	42.77	6.64
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.87	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.76	3.23
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.39	5.19
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.84	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	16.38	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	7.13
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	37.46	5.91
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	38.92	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	32.22	6.52
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	22.35	5.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	45.81	4.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	29.56	5.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	37.66	9.50
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.05	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	28.21	8.06
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	34.22	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	61.46	9.62
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	35.84	5.48
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	50.39	21.79
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	17.80	10.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	34.82	8.91
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	46.82	16.61
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	79.94
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	71.77
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	19.01
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	25.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	27.36	4.52
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	43.38	3.66
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	35.38	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	14.19	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	127.20	12.36
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	82.98	11.17
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	25.84	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	358.34	49.62
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	22.60	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	36.03	2.32
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	24.86	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	46.04	3.78
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	211.56	55.67
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	26.31	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	37.08	5.41
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	28.56	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	13.88	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	49.76	4.92
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	28.64	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	14.41	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	90.90	9.85
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	17.40	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	48.51	4.76
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	22.50	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	12.87	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.64	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	91.74	13.80
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	222.50	22.76
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	32.75	3.79
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	20.32	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	27.53	1.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	31.76	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	144.44	36.11
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.66	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	19.39	2.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.22	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	17.64	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.13	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.95	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.02	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	41.16	6.78
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.05	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	22.60	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	29.27	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	10.34	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	32.36	2.72
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.52	3.98
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	24.40	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	199.27	40.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.83	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.39	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.83	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	28.48	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	89.56	9.07
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	354.05	20.23
Myoblast, donor1	11241-116D8	41.49	12.55
Myoblast, donor2	11322-117D8	55.04	8.82
Myoblast, donor3	11398-118D3	46.24	8.24
NK T cell leukemia cell line:KHYG-1	10777-110G3	37.07	20.43
Natural Killer Cells, donor1	11230-116C6	14.15	11.69
Natural Killer Cells, donor2	11311-117C6	21.71	12.36
Natural Killer Cells, donor3	11387-118C1	14.54	10.68
Neural stem cells, donor1	11275-116H6	73.31	14.52
Neural stem cells, donor2	11352-117H2	28.88	5.78
Neurons, donor1	11494-119E9	59.17	11.38
Neurons, donor2	11574-120E8	59.22	6.60
Neurons, donor3	11655-122E8	94.55	17.27
Neutrophils, donor1	11233-116C9	2.78	0.93
Neutrophils, donor2	11314-117C9	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	27.90	2.26
Nucleus Pulposus Cell, donor2	11409-118E5	22.47	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	46.73	3.41
Olfactory epithelial cells, donor1	11933-125I7	31.11	2.34
Olfactory epithelial cells, donor2	11934-125I8	67.74	5.93
Olfactory epithelial cells, donor3	11935-125I9	39.50	2.16
Olfactory epithelial cells, donor4	11936-126A1	40.61	3.31
Oligodendrocyte - precursors, donor1	11496-119F2	61.39	6.62
Osteoblast - differentiated, donor1	11276-116H7	12.97	2.34
Osteoblast - differentiated, donor2	11353-117H3	10.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.17	0.00
Osteoblast, donor1	11277-116H8	18.96	0.39
Osteoblast, donor2	11354-117H4	68.12	9.13
Osteoblast, donor3	11426-118G4	23.99	1.78
Pancreatic stromal cells, donor1	11249-116E7	60.23	6.49
Pericytes, donor1	11491-119E6	10.57	2.45
Pericytes, donor2	11571-120E5	24.67	2.72
Pericytes, donor3	11652-122E5	36.01	4.88
Perineurial Cells, donor1	11499-119F5	57.41	7.46
Perineurial Cells, donor2	11579-120F4	35.06	7.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	21.36	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.98	5.39
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	12.94	6.21
Placental Epithelial Cells, donor1	11278-116H9	30.61	4.78
Placental Epithelial Cells, donor2	11355-117H5	19.96	0.00
Placental Epithelial Cells, donor3	11427-118G5	14.72	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	21.20	1.58
Preadipocyte - breast, donor1	11467-119B9	23.26	4.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.01	2.22
Preadipocyte - breast, donor2	11328-117E5	29.94	1.80
Preadipocyte - omental, donor1	11468-119C1	26.96	5.33
Preadipocyte - omental, donor2	11329-117E6	31.43	3.93
Preadipocyte - omental, donor3	11403-118D8	37.39	2.86
Preadipocyte - perirenal, donor1	11469-119C2	27.56	8.86
Preadipocyte - subcutaneous, donor1	11279-116I1	13.51	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	142.90	10.62
Preadipocyte - subcutaneous, donor3	11428-118G6	61.64	8.85
Preadipocyte - visceral, donor1	11280-116I2	95.48	12.67
Preadipocyte - visceral, donor2	11357-117H7	89.74	5.52
Preadipocyte - visceral, donor3	11429-118G7	114.00	11.18
Prostate Epithelial Cells (polarized), donor1	11253-116F2	83.27	26.10
Prostate Epithelial Cells, donor2	11331-117E8	28.03	4.33
Prostate Epithelial Cells, donor3	11404-118D9	22.35	1.47
Prostate Stromal Cells, donor1	11254-116F3	64.35	6.95
Prostate Stromal Cells, donor2	11332-117E9	87.32	8.07
Prostate Stromal Cells, donor3	11405-118E1	30.66	2.40
Renal Cortical Epithelial Cells, donor1	11516-119H4	37.96	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	64.74	5.34
Renal Epithelial Cells, donor1	11517-119H5	17.75	2.03
Renal Epithelial Cells, donor2	11597-120H4	49.08	2.85
Renal Epithelial Cells, donor3	11678-122H4	68.18	3.92
Renal Glomerular Endothelial Cells, donor1	11514-119H2	26.55	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	83.15	7.55
Renal Glomerular Endothelial Cells, donor3	11675-122H1	124.10	14.43
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.99	0.67
Renal Mesangial Cells, donor1	11518-119H6	29.27	3.08
Renal Mesangial Cells, donor2	11598-120H5	42.63	3.13
Renal Mesangial Cells, donor3	11679-122H5	13.32	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	68.98	5.64
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	54.40	2.53
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	53.61	2.31
Retinal Pigment Epithelial Cells, donor0	11215-116A9	119.79	15.82
Retinal Pigment Epithelial Cells, donor1	11528-119I7	37.80	4.55
Retinal Pigment Epithelial Cells, donor2	11608-120I6	57.63	5.15
Retinal Pigment Epithelial Cells, donor3	11689-122I6	34.37	3.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	92.34	33.81
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	64.33	5.36
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	148.05	14.31
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	121.23	9.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	191.92	33.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	159.09	15.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	145.67	21.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	255.41	35.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	203.02	15.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	219.11	26.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	135.54	20.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	166.85	16.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	135.47	18.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	158.09	24.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	166.87	15.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	192.06	21.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	112.22	17.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	158.19	14.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	156.34	19.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	134.70	17.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	149.13	12.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	181.60	18.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	141.39	20.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	154.45	15.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	164.40	16.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	130.18	20.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	157.34	15.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	167.50	14.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	140.11	15.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	170.44	14.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	185.44	23.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	152.82	23.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	190.46	15.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	160.84	17.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	172.27	24.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	134.02	12.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	183.93	19.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	168.50	23.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	128.12	11.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	225.57	22.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	111.63	15.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	147.37	12.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	125.55	12.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	78.12	11.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	132.38	13.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	133.02	14.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	85.23	14.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	75.81	11.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	62.26	9.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	115.04	23.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	90.97	27.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	68.75	14.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	99.16	22.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	54.29	5.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	47.63	8.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	72.97	19.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	49.95	4.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	56.49	11.42
Schwann Cells, donor1	11498-119F4	53.41	2.82
Schwann Cells, donor2	11578-120F3	74.85	0.00
Schwann Cells, donor3	11659-122F3	72.30	3.29
Sebocyte, donor1	11220-116B5	24.10	6.03
Sebocyte, donor2	11301-117B5	52.85	4.60
Sebocyte, donor3	11378-118B1	19.99	1.44
Sertoli Cells, donor1	11255-116F4	33.13	13.25
Sertoli Cells, donor2	11333-117F1	42.37	2.82
Skeletal Muscle Cells, donor1	11281-116I3	32.90	2.46
Skeletal Muscle Cells, donor2	11358-117H8	5.06	0.00
Skeletal Muscle Cells, donor3	11430-118G8	56.01	1.67
Skeletal Muscle Cells, donor4	11451-119A2	169.82	16.65
Skeletal Muscle Cells, donor5	11455-119A6	166.93	11.45
Skeletal Muscle Cells, donor6	11459-119B1	220.23	13.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	71.07	5.17
Skeletal Muscle Satellite Cells, donor2	11321-117D7	85.33	4.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	135.32	9.52
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	33.79	3.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	28.23	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	24.08	1.65
Skin - palm, donor1	10286-104F7	8.06	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	24.79	1.30
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	17.99	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	26.74	1.69
Small Airway Epithelial Cells, donor1	11256-116F5	26.41	4.03
Small Airway Epithelial Cells, donor2	11334-117F2	16.88	3.80
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	31.93	8.67
Small Airway Epithelial Cells, donor3	11406-118E2	14.17	3.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	37.34	9.57
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	21.57	3.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	31.74	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	13.48	2.21
Smooth Muscle Cells - Aortic, donor2	11360-117I1	14.96	1.97
Smooth Muscle Cells - Aortic, donor3	11432-118H1	36.31	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	27.02	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.02	1.20
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	56.08	8.20
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	42.89	7.55
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	53.40	5.21
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	56.11	6.20
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	41.86	3.84
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	32.21	5.69
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	30.14	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.91	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	26.23	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	53.68	6.34
Smooth Muscle Cells - Colonic, donor2	11320-117D6	64.79	9.69
Smooth Muscle Cells - Colonic, donor3	11396-118D1	73.79	5.46
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	18.10	1.70
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	25.87	4.31
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	38.85	3.29
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	27.99	2.73
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	30.16	2.98
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	42.07	4.63
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	43.69	8.19
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	27.17	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	215.12	27.02
Smooth Muscle Cells - Prostate, donor1	11257-116F6	61.25	10.65
Smooth Muscle Cells - Prostate, donor2	11335-117F3	54.97	5.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	20.55	2.79
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.02	4.07
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	18.09	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.07	3.26
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	37.87	4.54
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	26.01	3.45
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	27.73	2.36
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	96.39	10.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	29.90	3.27
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	16.26	1.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	34.42	3.82
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	36.85	2.82
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	103.69	11.04
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	38.54	4.86
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	20.55	3.18
Smooth Muscle Cells - Uterine, donor1	11258-116F7	70.04	11.05
Smooth Muscle Cells - Uterine, donor3	11466-119B8	116.15	11.12
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	23.13	2.53
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	41.25	4.23
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	65.46	6.70
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	45.28	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	41.17	3.69
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	102.80	7.88
Smooth muscle cells - airway, control, donor1	11966-126D4	52.57	4.06
Smooth muscle cells - airway, control, donor2	11967-126D5	31.15	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	36.78	5.85
Smooth muscle cells - airway, control, donor4	11969-126D7	27.04	1.38
Synoviocyte, donor1	11291-117A4	26.26	5.89
Synoviocyte, donor2	11368-117I9	29.00	4.02
Synoviocyte, donor3	11440-118H9	40.21	4.47
Trabecular Meshwork Cells, donor1	11532-120A2	52.53	6.43
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.82	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	32.90	4.73
Tracheal Epithelial Cells, donor2	11369-118A1	16.24	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	17.18	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	91.16	32.48
Urethra, donor2	10319-105A4	25.18	1.80
Urothelial Cells, donor1	11520-119H8	14.61	5.05
Urothelial Cells, donor2	11600-120H7	23.63	2.00
Urothelial Cells, donor3	11681-122H7	10.31	0.92
Urothelial cells, donor0	11216-116B1	45.47	2.23
Whole blood (ribopure), donor090309, donation1	12179-129A1	15.13	5.34
Whole blood (ribopure), donor090309, donation2	12180-129A2	22.87	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.06	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	25.48	3.10
Whole blood (ribopure), donor090325, donation2	12177-128I8	21.50	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	16.66	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	23.86	4.59
Whole blood (ribopure), donor090612, donation3	12184-129A6	12.78	0.91
Wilms' tumor cell line:G-401	10809-111A8	160.62	24.92
Wilms' tumor cell line:HFWT	10597-108E3	71.28	6.16
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	162.56	12.57
achilles tendon, donor2	10292-104G4	12.40	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	304.93	119.83
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	138.61	25.77
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	47.72	14.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	314.84	44.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	291.48	28.39
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	89.67	12.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	63.15	13.61
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	209.30	36.13
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	111.48	10.62
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	94.36	22.91
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	261.28	31.83
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	70.21	15.60
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	177.07	17.89
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	198.06	31.59
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	149.92	17.83
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	54.84	6.04
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	96.64	9.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	98.84	4.60
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	218.47	19.20
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	139.52	18.20
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	189.44	19.74
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	384.22	28.07
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	147.76	13.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	206.26	31.59
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	284.00	24.48
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	64.55	11.78
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	74.98	20.62
adenocarcinoma cell line:IM95m	10796-110I4	104.80	18.13
adipose tissue, adult, pool1	10010-101C1	24.20	2.95
adipose, donor1	10184-103D4	288.51	40.46
adipose, donor2	10185-103D5	50.69	8.11
adipose, donor3	10186-103D6	107.01	17.15
adipose, donor4	10187-103D7	303.36	17.34
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	177.55	9.00
adrenal gland, adult, pool1	10081-102A9	72.75	32.74
adult T-cell leukemia cell line:ATN-1	10421-106C7	54.16	7.74
alveolar cell carcinoma cell line:SW 1573	10708-109H6	215.09	21.08
amniotic membrane cells, donor1	12235-129G3	21.56	5.80
amniotic membrane cells, donor2	12236-129G4	40.91	4.06
amniotic membrane cells, donor3	12237-129G5	26.81	5.60
amygdala - adult, donor10196	10167-103B5	111.46	9.49
amygdala, adult, donor10252	10151-102I7	85.16	12.57
amygdala, newborn, donor10223	10360-105E9	126.85	13.56
anaplastic carcinoma cell line:8305C	10428-106D5	37.18	2.67
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	176.28	34.20
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	119.25	12.69
aorta, adult, pool1	10052-101G7	42.36	8.04
appendix, adult	10189-103D9	54.72	3.49
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	137.92	30.27
artery, adult	10190-103E1	38.04	5.43
astrocytoma cell line:TM-31	10425-106D2	27.96	5.36
b cell line:RPMI1788	10427-106D4	71.23	21.26
basal cell carcinoma cell line:TE 354.T	10702-109G9	23.86	3.88
bile duct carcinoma cell line:HuCCT1	10432-106D9	52.00	8.73
bile duct carcinoma cell line:TFK-1	10496-107C1	43.35	11.55
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	36.35	6.15
bladder, adult, pool1	10011-101C2	31.83	5.21
blood, adult, pool1	10053-101G8	11.07	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	35.97	5.99
bone marrow, adult	10192-103E3	51.29	8.10
brain, adult, donor1	10084-102B3	50.23	6.15
brain, adult, pool1	10012-101C3	46.33	7.35
brain, fetal, pool1	10085-102B4	61.44	8.01
breast carcinoma cell line:MCF7	10482-107A5	104.73	13.54
breast carcinoma cell line:MDA-MB-453	10419-106C5	45.06	12.98
breast, adult, donor1	10080-102A8	71.34	5.68
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	233.37	10.16
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	164.51	17.32
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	202.59	6.68
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	153.72	29.05
carcinoid cell line:NCI-H1770	10703-109H1	136.82	13.16
carcinoid cell line:NCI-H727	10735-110B6	43.21	11.16
carcinoid cell line:SK-PN-DW	10719-109I8	246.23	30.74
carcinosarcoma cell line:JHUCS-1	10642-109A3	119.78	8.52
caudate nucleus - adult, donor10196	10177-103C6	138.16	5.76
caudate nucleus, adult, donor10252	10164-103B2	70.11	11.04
caudate nucleus, adult, donor10258	10379-105H1	71.06	6.88
caudate nucleus, newborn, donor10223	10354-105E3	149.79	16.85
cerebellum - adult, donor10196	10173-103C2	104.88	5.83
cerebellum, adult, donor10252	10166-103B4	53.59	6.41
cerebellum, adult, pool1	10083-102B2	40.01	3.79
cerebellum, newborn, donor10223	10357-105E6	51.48	11.62
cerebral meninges, adult	10188-103D8	67.07	9.58
cerebrospinal fluid, donor2	10294-104G6	38.74	6.58
cervical cancer cell line:D98-AH2	10552-107I3	47.45	14.67
cervical cancer cell line:ME-180	10553-107I4	28.34	10.61
cervix, adult, pool1	10013-101C4	27.72	3.46
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	43.61	9.20
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	5.23
choriocarcinoma cell line:BeWo	10423-106C9	138.69	27.09
choriocarcinoma cell line:SCH	10785-110H2	47.31	6.04
choriocarcinoma cell line:T3M-3	10618-108G6	150.13	12.81
chorionic membrane cells, donor1	12238-129G6	25.93	3.99
chorionic membrane cells, donor2	12239-129G7	33.31	5.07
chorionic membrane cells, donor3	12240-129G8	32.42	6.59
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	122.19	43.42
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	167.13	34.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	98.20	14.15
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	93.48	15.66
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	102.80	10.64
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	97.12	14.25
chronic myelogenous leukemia cell line:K562	10454-106G4	191.69	26.50
chronic myelogenous leukemia cell line:KU812	10409-106B4	69.33	11.73
clear cell carcinoma cell line:JHOC-5	10638-108I8	151.78	7.09
clear cell carcinoma cell line:TEN	10636-108I6	118.16	17.18
colon carcinoma cell line:CACO-2	10513-107D9	129.59	34.78
colon carcinoma cell line:COLO-320	10420-106C6	71.08	14.06
colon, adult, donor1	10082-102B1	52.36	8.33
colon, adult, pool1	10014-101C5	31.84	10.69
colon, fetal, donor1	10070-101I7	42.64	4.33
common myeloid progenitor CMP, donor1	12130-128D6	9.17	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	90.51	30.60
cord blood derived cell line:COBL-a 24h infection	10453-106G3	138.71	33.20
cord blood derived cell line:COBL-a untreated	10449-106F8	164.70	36.10
corpus callosum, adult, pool1	10042-101F6	28.75	9.95
cruciate ligament, donor2	10295-104G7	25.12	3.24
diaphragm, fetal, donor1	10069-101I6	42.54	6.42
diencephalon, adult	10193-103E4	55.44	15.12
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	215.15	35.82
ductal cell carcinoma cell line:KLM-1	10438-106E6	48.98	7.44
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	78.72	22.63
ductus deferens, adult	10196-103E7	40.37	6.48
duodenum, fetal, donor1, tech_rep1	10071-101I8	64.81	8.64
duodenum, fetal, donor1, tech_rep2	10071-101I8	50.02	8.09
dura mater, adult, donor1	10041-101F5	18.42	2.06
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	21.54	13.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	93.43	34.39
embryonic pancreas cell line:1B2C6	10604-108F1	78.93	4.32
embryonic pancreas cell line:1C3D3	10605-108F2	74.77	4.24
embryonic pancreas cell line:1C3IKEI	10606-108F3	73.48	4.63
embryonic pancreas cell line:2C6	10603-108E9	90.63	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	103.91	17.43
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	78.11	5.62
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	108.71	11.10
epidermoid carcinoma cell line:A431	10426-106D3	66.92	12.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	80.84	14.41
epididymis, adult	10197-103E8	32.86	4.81
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	70.79	4.26
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	40.90	7.47
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	155.95	23.85
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	87.50	9.45
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	152.14	17.59
esophagus, adult, pool1	10015-101C6	29.41	3.93
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	69.26	8.27
eye - muscle inferior rectus, donor1	10272-104E2	41.05	4.83
eye - muscle lateral, donor2	10298-104H1	39.98	0.00
eye - muscle medial, donor2	10299-104H2	19.35	4.46
eye - muscle superior, donor2	10297-104G9	38.98	6.88
eye - vitreous humor, donor1	10268-104D7	33.52	8.74
eye, fetal, donor1	10054-101G9	32.80	4.58
fibrosarcoma cell line:HT-1080	10758-110E2	80.78	9.49
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	233.86	10.92
frontal lobe, adult, pool1	10040-101F4	35.37	5.63
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	47.74	11.41
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	112.56	5.39
gall bladder, adult	10198-103E9	32.83	6.04
gamma delta positive T cells, donor1	11937-126A2	31.14	3.22
gamma delta positive T cells, donor2	11938-126A3	22.41	3.36
gastric adenocarcinoma cell line:MKN1	10614-108G2	55.76	14.79
gastric adenocarcinoma cell line:MKN45	10612-108F9	72.34	16.25
gastric cancer cell line:AZ521	10549-107H9	81.16	11.48
gastric cancer cell line:GSS	10560-108A2	118.98	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	59.17	15.08
giant cell carcinoma cell line:LU65	10487-107B1	65.40	15.83
giant cell carcinoma cell line:Lu99B	10433-106E1	85.80	17.91
glassy cell carcinoma cell line:HOKUG	10688-109F4	73.83	21.20
glioblastoma cell line:A172, tech_rep1	10444-106F3	77.79	12.35
glioblastoma cell line:A172, tech_rep2	10444-106F3	94.94	17.27
glioblastoma cell line:T98G	10485-107A8	50.66	10.82
glioma cell line:GI-1	10413-106B8	43.35	8.79
globus pallidus - adult, donor10196	10175-103C4	73.62	8.02
globus pallidus, adult, donor10252	10161-103A8	91.29	15.62
globus pallidus, adult, donor10258	10367-105F7	68.46	5.48
globus pallidus, newborn, donor10223	10364-105F4	71.41	7.99
granulocyte macrophage progenitor, donor1	12131-128D7	9.79	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	73.17	20.91
granulosa cell tumor cell line:KGN	10624-108H3	39.68	6.40
hIPS +CCl2, biol_rep1	14383-156B9	336.53	29.38
hIPS +CCl2, biol_rep2	14384-156C1	267.96	15.09
hIPS +CCl2, biol_rep3	14385-156C2	275.67	16.75
hIPS, biol_rep1	14380-156B6	158.10	12.94
hIPS, biol_rep2	14381-156B7	233.19	14.40
hIPS, biol_rep3	14382-156B8	94.90	7.72
hairy cell leukemia cell line:Mo	10712-109I1	106.03	16.67
heart - mitral valve, adult	10205-103F7	58.60	8.07
heart - pulmonic valve, adult	10206-103F8	41.05	4.97
heart - tricuspid valve, adult	10207-103F9	116.57	18.32
heart, adult, diseased post-infarction, donor1	10050-101G5	60.60	5.71
heart, adult, diseased, donor1	10051-101G6	36.20	5.11
heart, adult, pool1	10016-101C7	37.49	7.82
heart, fetal, pool1	10046-101G1	33.06	6.98
hepatic mesenchymal tumor cell line:LI90	10778-110G4	25.92	5.24
hepatoblastoma cell line:HuH-6	10633-108I3	155.78	28.54
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	340.11	93.26
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	326.86	95.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	300.13	96.30
hepatoma cell line:Li-7	10484-107A7	31.14	16.02
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	106.33	29.75
hippocampus - adult, donor10196	10169-103B7	118.29	9.46
hippocampus, adult, donor10252	10153-102I9	84.70	15.72
hippocampus, adult, donor10258	10374-105G5	36.35	2.49
hippocampus, newborn, donor10223	10363-105F3	74.02	9.87
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	908.19	62.87
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	326.34	22.97
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	353.17	22.34
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	69.36	4.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	133.24	9.04
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	85.03	7.97
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	74.16	10.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	67.86	10.77
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	70.90	8.76
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	90.69	26.05
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	111.06	15.91
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	96.96	23.57
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	289.81	20.34
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	472.62	28.50
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	736.60	35.78
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	77.32	5.92
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	64.54	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	149.93	8.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	41.63	7.35
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	56.38	8.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	51.06	7.83
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	65.48	14.86
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	61.55	13.64
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	68.75	7.47
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	322.56	21.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	303.83	16.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	547.55	34.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	109.50	10.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	73.17	7.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	78.38	6.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	46.02	7.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	61.77	9.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	60.80	8.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	87.43	16.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	100.71	12.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	105.19	10.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	301.88	15.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	496.46	25.40
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	349.27	15.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	69.38	7.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1044.29	74.82
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	132.71	5.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	72.79	9.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	54.28	5.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	54.80	6.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	94.28	7.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	73.67	15.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	103.99	10.51
immature langerhans cells, donor1	11904-125F5	36.56	13.56
immature langerhans cells, donor2	11905-125F6	22.18	10.30
insula, adult, pool1	10039-101F3	31.51	6.06
keratoacanthoma cell line:HKA-1	10791-110H8	100.15	14.31
kidney, adult, pool1	10017-101C8	63.98	15.92
kidney, fetal, pool1	10045-101F9	22.56	5.94
large cell lung carcinoma cell line:IA-LM	10509-107D5	53.97	12.21
large cell lung carcinoma cell line:NCI-H460	10839-111E2	63.18	54.33
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	49.18	4.40
left atrium, adult, donor1	10079-102A7	54.49	4.36
left ventricle, adult, donor1	10078-102A6	57.14	5.06
leiomyoblastoma cell line:G-402	10721-110A1	213.96	20.79
leiomyoma cell line:10964C	10569-108B2	54.61	7.54
leiomyoma cell line:15242A	10570-108B3	58.15	9.24
leiomyoma cell line:15425	10571-108B4	76.73	5.83
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	43.91	7.32
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	98.34	28.45
liposarcoma cell line:KMLS-1	10782-110G8	74.04	13.28
liposarcoma cell line:SW 872	10726-110A6	49.22	5.12
liver, adult, pool1	10018-101C9	66.45	27.55
liver, fetal, pool1	10086-102B5	44.21	13.17
locus coeruleus - adult, donor10196	10182-103D2	97.70	11.37
locus coeruleus, adult, donor10252	10165-103B3	82.49	16.24
locus coeruleus, adult, donor10258	10375-105G6	58.97	6.21
locus coeruleus, newborn, donor10223	10362-105F2	135.44	15.14
lung adenocarcinoma cell line:A549	10499-107C4	56.74	13.84
lung adenocarcinoma cell line:PC-14	10408-106B3	84.80	12.41
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	57.34	4.75
lung, adult, pool1	10019-101D1	31.30	8.03
lung, fetal, donor1	10068-101I5	75.92	10.85
lung, right lower lobe, adult, donor1	10075-102A3	55.44	3.21
lymph node, adult, donor1	10077-102A5	35.03	1.42
lymphangiectasia cell line:DS-1	10727-110A7	49.53	10.74
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	193.04	31.69
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	37.38	6.80
mature adipocyte, donor1	12231-129F8	23.98	17.32
mature adipocyte, donor2	12232-129F9	23.66	12.24
mature adipocyte, donor3	12233-129G1	32.24	15.88
mature adipocyte, donor4	12234-129G2	34.48	15.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	79.10	22.87
medial frontal gyrus - adult, donor10196	10170-103B8	144.39	10.15
medial frontal gyrus, adult, donor10252	10150-102I6	90.85	13.06
medial frontal gyrus, adult, donor10258	10368-105F8	82.28	13.03
medial frontal gyrus, newborn, donor10223	10352-105E1	203.86	38.81
medial temporal gyrus - adult, donor10196	10183-103D3	168.41	13.50
medial temporal gyrus, adult, donor10252	10156-103A3	91.68	10.40
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	200.95	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	86.86	14.36
medulla oblongata - adult, donor10196	10174-103C3	120.71	13.63
medulla oblongata, adult, donor10252	10155-103A2	77.87	23.22
medulla oblongata, adult, pool1	10038-101F2	28.49	7.51
medulla oblongata, newborn, donor10223	10361-105F1	71.52	9.03
medulloblastoma cell line:D283 Med	10838-111E1	121.78	15.06
medulloblastoma cell line:ONS-76	10759-110E3	124.23	18.59
melanoma cell line:COLO 679	10514-107E1	34.93	21.71
melanoma cell line:G-361	10465-106H6	45.88	39.63
meningioma cell line:HKBMM	10691-109F7	66.21	11.40
merkel cell carcinoma cell line:MKL-1	10843-111E6	147.15	21.15
merkel cell carcinoma cell line:MS-1	10844-111E7	104.99	18.40
mesenchymal precursor cell - adipose, donor1	11747-123G1	94.52	21.17
mesenchymal precursor cell - adipose, donor2	11748-123G2	39.45	7.63
mesenchymal precursor cell - adipose, donor3	11749-123G3	65.84	5.38
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	45.09	13.35
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	48.91	10.98
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	29.85	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	29.69	6.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.04	10.01
mesenchymal precursor cell - cardiac, donor3	11754-123G8	81.44	14.32
mesenchymal precursor cell - cardiac, donor4	11755-123G9	87.37	16.47
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	71.98	14.51
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	32.61	6.59
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	47.74	13.98
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	77.85	10.12
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	46.96	6.94
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.49	2.88
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	45.52	7.66
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	29.64	4.79
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	153.56	8.81
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	49.61	11.06
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	48.75	8.40
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	34.24	2.95
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	29.76	2.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	95.57	6.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	40.19	6.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	37.86	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	37.43	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	35.43	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	32.95	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	31.81	3.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.12	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	26.41	3.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	38.94	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	26.77	2.90
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	27.16	2.40
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	22.73	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	31.55	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	29.07	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	34.79	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	43.75	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	32.80	3.25
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	43.71	4.26
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	41.71	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	44.70	2.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	39.74	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	39.14	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	35.34	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	35.47	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	28.28	2.41
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	21.19	3.26
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	27.01	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.40	4.13
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	29.92	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	52.04	10.64
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	61.63	15.41
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	53.01	8.95
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	73.23	17.81
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	65.05	13.46
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	50.25	17.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	59.24	10.88
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	50.15	8.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	35.48	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	38.23	11.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	54.23	31.63
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	30.48	6.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	52.38	9.52
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	50.62	9.09
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	32.60	6.11
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	85.52	7.32
mesothelioma cell line:ACC-MESO-4	10494-107B8	60.93	11.58
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	98.95	18.70
mesothelioma cell line:Mero-25	10850-111F4	24.51	3.40
mesothelioma cell line:Mero-41	10851-111F5	115.88	6.36
mesothelioma cell line:Mero-48a	10852-111F6	99.20	7.97
mesothelioma cell line:Mero-82	10853-111F7	33.11	8.67
mesothelioma cell line:Mero-83	10854-111F8	38.98	9.36
mesothelioma cell line:Mero-84	10855-111F9	94.79	11.63
mesothelioma cell line:Mero-95	10856-111G1	70.60	7.45
mesothelioma cell line:NCI-H2052	10847-111F1	107.34	9.94
mesothelioma cell line:NCI-H226	10846-111E9	110.04	21.54
mesothelioma cell line:NCI-H2452	10848-111F2	93.44	8.03
mesothelioma cell line:NCI-H28	10845-111E8	171.00	40.71
mesothelioma cell line:No36	10857-111G2	112.21	16.31
mesothelioma cell line:ONE58	10858-111G3	99.17	18.97
migratory langerhans cells, donor1	11901-125F2	54.12	7.29
migratory langerhans cells, donor2	11902-125F3	31.26	2.93
migratory langerhans cells, donor3	11903-125F4	50.25	6.46
mixed mullerian tumor cell line:HTMMT	10689-109F5	55.17	4.57
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	107.03	14.62
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	47.45	8.52
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	79.73	18.65
myelodysplastic syndrome cell line:SKM-1	10772-110F7	190.15	29.38
myeloma cell line:PCM6	10474-106I6	22.34	5.14
myxofibrosarcoma cell line:MFH-ino	10600-108E6	73.05	5.07
myxofibrosarcoma cell line:NMFH-1	10684-109E9	73.75	16.87
nasal epithelial cells, donor1, tech_rep1	12226-129F3	29.75	4.68
nasal epithelial cells, donor1, tech_rep2	12226-129F3	46.18	3.60
nasal epithelial cells, donor2	12227-129F4	22.08	1.66
neuroblastoma cell line:CHP-134	10508-107D4	67.41	24.62
neuroblastoma cell line:NB-1	10539-107G8	178.48	43.78
neuroblastoma cell line:NBsusSR	10607-108F4	37.54	17.08
neuroblastoma cell line:NH-12	10555-107I6	87.03	27.02
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	60.73	10.91
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	111.34	17.58
neuroectodermal tumor cell line:TASK1	10774-110F9	116.13	12.28
neuroepithelioma cell line:SK-N-MC	10728-110A8	82.01	7.63
neurofibroma cell line:Hs 53.T	10729-110A9	41.26	4.52
neutrophil PMN, donor1	12133-128D9	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	88.28	16.74
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	193.72	67.24
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	45.21	7.37
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	42.04	3.15
nucleus accumbens, adult, pool1	10037-101F1	34.50	5.81
occipital cortex - adult, donor10196	10172-103C1	197.80	8.24
occipital cortex, adult, donor10252	10163-103B1	83.46	17.18
occipital cortex, newborn, donor10223	10355-105E4	81.52	12.74
occipital lobe, adult, donor1	10076-102A4	72.42	8.92
occipital lobe, fetal, donor1	10073-102A1	108.13	5.15
occipital pole, adult, pool1	10036-101E9	17.11	3.78
olfactory region, adult	10195-103E6	58.08	7.45
optic nerve, donor1	10277-104E7	22.01	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	48.87	20.50
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	226.28	36.54
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	60.96	7.62
oral squamous cell carcinoma cell line:SAS	10544-107H4	45.86	12.24
osteoclastoma cell line:Hs 706.T	10704-109H2	20.28	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	103.71	12.15
osteosarcoma cell line:HS-Os-1	10558-107I9	44.74	9.75
ovary, adult, pool1	10020-101D2	26.47	3.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	39.60	6.05
pancreas, adult, donor1	10049-101G4	84.66	13.17
pancreatic carcinoma cell line:NOR-P1	10698-109G5	132.50	19.57
papillary adenocarcinoma cell line:8505C	10437-106E5	78.87	6.98
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	60.77	9.77
paracentral gyrus, adult, pool1	10035-101E8	31.12	5.67
parietal cortex, adult, donor10258	10373-105G4	66.79	5.14
parietal lobe - adult, donor10196	10171-103B9	98.75	8.46
parietal lobe, adult, donor10252	10157-103A4	88.93	12.26
parietal lobe, adult, pool1	10034-101E7	31.37	6.61
parietal lobe, fetal, donor1	10072-101I9	133.84	9.70
parietal lobe, newborn, donor10223	10356-105E5	91.22	15.70
parotid gland, adult	10199-103F1	36.38	4.32
penis, adult	10200-103F2	37.60	5.91
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	56.90	10.41
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	116.99	11.51
pineal gland - adult, donor10196	10179-103C8	45.15	3.23
pineal gland, adult, donor10252	10160-103A7	43.82	7.11
pineal gland, adult, donor10258	10377-105G8	26.96	5.02
pituitary gland - adult, donor10196	10180-103C9	101.18	5.06
pituitary gland, adult, donor10252	10162-103A9	93.81	16.68
pituitary gland, adult, donor10258	10378-105G9	47.67	7.66
placenta, adult, pool1	10021-101D3	26.77	4.09
plasma cell leukemia cell line:ARH-77	10840-111E3	136.13	15.23
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	77.20	9.34
pons, adult, pool1	10033-101E6	31.16	6.54
postcentral gyrus, adult, pool1	10032-101E5	31.03	5.32
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	11.74
prostate cancer cell line:DU145	10490-107B4	104.44	6.55
prostate cancer cell line:PC-3	10439-106E7	151.01	21.42
prostate, adult, pool1	10022-101D4	30.20	5.99
putamen, adult, donor10196	10176-103C5	93.95	10.39
putamen, adult, donor10252	10152-102I8	100.00	21.57
putamen, adult, donor10258, tech_rep1	10372-105G3	114.75	25.13
putamen, adult, donor10258, tech_rep2	10372-105G3	49.53	1.69
putamen, newborn, donor10223	10365-105F5	155.93	26.99
rectal cancer cell line:TT1TKB	10469-106I1	40.73	9.31
rectum, fetal, donor1	10067-101I4	45.90	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	43.25	5.94
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	25.27	4.56
retina, adult, pool1	10030-101E3	22.07	3.48
retinoblastoma cell line:Y79	10475-106I7	121.33	28.58
rhabdomyosarcoma cell line:KYM-1	10787-110H4	147.42	11.93
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	157.19	18.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	19.70	2.27
salivary acinar cells, donor1	11771-123I7	56.33	9.87
salivary acinar cells, donor2	11772-123I8	49.43	9.50
salivary acinar cells, donor3	11773-123I9	20.52	5.30
salivary gland, adult, pool1	10093-102C3	41.75	9.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	72.68	7.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	94.75	13.05
seminal vesicle, adult	10201-103F3	47.62	4.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	85.51	13.12
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	58.63	13.84
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	169.60	19.07
serous cystadenocarcinoma cell line:HTOA	10693-109F9	59.64	12.89
signet ring carcinoma cell line:Kato III	10436-106E4	31.39	17.46
signet ring carcinoma cell line:NUGC-4	10483-107A6	148.25	47.74
skeletal muscle - soleus muscle, donor1	10282-104F3	39.72	12.06
skeletal muscle, adult, pool1	10023-101D5	27.47	6.60
skeletal muscle, fetal, donor1	10066-101I3	54.27	5.03
skin, adult, donor1	10074-102A2	61.07	6.79
skin, fetal, donor1	10065-101I2	71.33	6.94
small cell cervical cancer cell line:HCSC-1	10800-110I8	80.38	19.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	113.16	41.92
small cell lung carcinoma cell line:DMS 144	10841-111E4	270.42	10.60
small cell lung carcinoma cell line:LK-2	10541-107H1	58.84	27.03
small cell lung carcinoma cell line:NCI-H82	10842-111E5	200.42	13.51
small cell lung carcinoma cell line:WA-hT	10562-108A4	92.18	39.44
small intestine, adult, pool1	10024-101D6	30.10	14.33
small intestine, fetal, donor1	10064-101I1	79.85	10.81
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	90.78	41.03
smooth muscle, adult, pool1	10048-101G3	30.76	5.43
somatostatinoma cell line:QGP-1	10781-110G7	42.88	18.23
spinal cord - adult, donor10196	10181-103D1	147.74	16.52
spinal cord, adult, donor10252	10159-103A6	74.52	24.84
spinal cord, adult, donor10258	10369-105F9	91.32	14.53
spinal cord, fetal, donor1	10056-101H2	78.06	12.20
spinal cord, newborn, donor10223	10359-105E8	130.88	17.91
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	31.36	3.14
spleen, adult, pool1	10025-101D7	28.97	4.63
spleen, fetal, pool1	10044-101F8	29.08	6.36
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	74.43	21.01
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	58.86	8.16
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	89.11	8.39
squamous cell carcinoma cell line:T3M-5	10616-108G4	37.53	3.52
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	43.00	15.65
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	144.02	17.37
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	92.65	10.58
stomach, fetal, donor1	10062-101H8	61.94	4.27
submaxillary gland, adult	10202-103F4	41.02	5.13
substantia nigra - adult, donor10196	10178-103C7	108.55	54.27
substantia nigra, adult, donor10252	10158-103A5	84.33	23.26
substantia nigra, adult, donor10258	10371-105G2	58.97	5.69
substantia nigra, newborn, donor10223	10358-105E7	85.50	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	127.24	24.30
temporal lobe, adult, pool1	10031-101E4	23.91	3.81
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	109.69	9.26
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	50.99	3.08
tenocyte, donor1	11763-123H8	52.71	3.14
tenocyte, donor2	11765-123I1	35.48	2.67
tenocyte, donor3	11768-123I4	36.70	4.08
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	408.08	45.72
teratocarcinoma cell line:NCR-G1	10798-110I6	120.24	9.40
teratocarcinoma cell line:PA-1	10807-111A6	204.73	8.83
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	150.05	17.39
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	260.94	15.88
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	126.08	12.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	340.03	12.70
testis, adult, pool1	10026-101D8	23.19	1.93
testis, adult, pool2	10096-102C6	31.12	3.61
thalamus - adult, donor10196	10168-103B6	121.44	20.98
thalamus, adult, donor10252	10154-103A1	80.80	17.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	9.24
thalamus, adult, donor10258, tech_rep2	10370-105G1	52.37	2.64
thalamus, newborn, donor10223	10366-105F6	118.52	21.29
throat, adult	10209-103G2	33.96	3.75
throat, fetal, donor1	10061-101H7	41.74	3.96
thymic carcinoma cell line:Ty-82	10803-111A2	182.04	19.87
thymus, adult, pool1	10027-101D9	20.48	1.59
thymus, fetal, pool1	10043-101F7	46.45	17.98
thyroid carcinoma cell line:KHM-5M	10776-110G2	165.67	22.34
thyroid carcinoma cell line:TCO-1	10783-110G9	69.98	4.47
thyroid, adult, pool1	10028-101E1	53.84	9.05
thyroid, fetal, donor1	10060-101H6	57.74	6.06
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	0.00
tongue, adult	10203-103F5	47.45	8.84
tongue, fetal, donor1	10059-101H5	96.55	9.06
tonsil, adult, pool1	10047-101G2	25.34	4.71
trachea, adult, pool1	10029-101E2	37.05	8.92
trachea, fetal, donor1	10058-101H4	55.78	7.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	86.80	9.57
transitional-cell carcinoma cell line:5637	10418-106C4	65.15	14.49
transitional-cell carcinoma cell line:JMSU1	10492-107B6	147.13	8.46
tridermal teratoma cell line:HGRT	10694-109G1	57.08	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	54.01	12.44
umbilical cord, fetal, donor1	10057-101H3	41.73	0.00
uterus, adult, pool1	10100-102D1	40.44	5.63
uterus, fetal, donor1	10055-101H1	72.18	3.58
vagina, adult	10204-103F6	99.51	22.62
vein, adult	10191-103E2	33.32	3.29
xeroderma pigentosum b cell line:XPL 17	10563-108A5	40.59	13.35